Compare

Up to four compounds, side by side.

Search or pick a starting set. Differences light up so you can spot them fast.

Tesamorelin
1 / 4
Peptide
Growth Hormone Releasing Hormone Analog
Tesamorelin
Overview
Summary
The visceral-fat peptide — FDA-approved for HIV-associated lipodystrophy.
Category
Growth Hormone Releasing Hormone Analog
Mechanism
A stabilized GHRH analog. Selectively reduces visceral adipose tissue in studied populations.
Effects
Top outcomes
  • Fat loss92
  • Cognition60
  • Lean muscle55
Evidence
Established
Practical
Half-life
~26 min (peptide), but downstream GH effect lasts hours
Administration
subq
Risk
Legal status
rx only
Safety
Generally well tolerated; injection-site reactions most common.
Try a preset